How does Insmed (INSM) make money?

Insmed (INSM) primarily makes money through Reportable Segment, which accounts for 100% of total revenue. For TTM through Q4 2025, Insmed generated $606.42M in total revenue with a net profit margin of -210.5%.

What is Insmed (INSM) gross profit margin?

Insmed (INSM) reported a gross profit margin of 79.4% for TTM through Q4 2025, equivalent to $481.55M in gross profit. This means Insmed retains 79.4% of each revenue unit after direct costs of production.

What is Insmed (INSM) operating profit margin?

Insmed (INSM) reported an operating profit margin of -194% for TTM through Q4 2025, equivalent to −$1.18B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.

What is Insmed (INSM) net profit margin?

Insmed (INSM) reported a net profit margin of -210.5% for TTM through Q4 2025, equivalent to −$1.28B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.

How much does Insmed (INSM) invest in R&D?

Insmed (INSM) invested $771.09M in research and development in TTM through Q4 2025 (127.2% of total revenue). R&D spending reflects investment in future products, services, and technologies.

How much does Insmed (INSM) spend on capital expenditures?

Insmed (INSM) spent $62.56M on capital expenditures in TTM through Q4 2025 (10.3% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.

What is Insmed (INSM) free cash flow?

Insmed (INSM) generated −$997.58M in free cash flow for TTM through Q4 2025 (-164.5% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

How Insmed (INSM) Makes Money: A Visual Guide

Insmed (INSM) generated $606.42M in revenue but reported a net loss of $1.28B. Its largest revenue source is Reportable Segment (100% of revenue). Below is an interactive breakdown of how revenue flows through the income statement.

Insmed (INSM) Income Statement Flow — TTM through Q4 2025

Calculated from the four most recent reported quarters, ending December 31, 2025 (reported February 19, 2026).

Frequently asked questions

How does Insmed (INSM) make money?: Insmed (INSM) primarily makes money through Reportable Segment, which accounts for 100% of total revenue. For TTM through Q4 2025, Insmed generated $606.42M in total revenue with a net profit margin of -210.5%.
What is Insmed (INSM) gross profit margin?: Insmed (INSM) reported a gross profit margin of 79.4% for TTM through Q4 2025, equivalent to $481.55M in gross profit. This means Insmed retains 79.4% of each revenue unit after direct costs of production.
What is Insmed (INSM) operating profit margin?: Insmed (INSM) reported an operating profit margin of -194% for TTM through Q4 2025, equivalent to −$1.18B in operating profit. This reflects profitability after operating expenses such as R&D, sales, and administration, but before taxes and non-operating items.
What is Insmed (INSM) net profit margin?: Insmed (INSM) reported a net profit margin of -210.5% for TTM through Q4 2025, equivalent to −$1.28B in net profit. This is the share of revenue that remains as profit after all expenses, taxes, and non-operating items.
How much does Insmed (INSM) invest in R&D?: Insmed (INSM) invested $771.09M in research and development in TTM through Q4 2025 (127.2% of total revenue). R&D spending reflects investment in future products, services, and technologies.
How much does Insmed (INSM) spend on capital expenditures?: Insmed (INSM) spent $62.56M on capital expenditures in TTM through Q4 2025 (10.3% of total revenue). Capital expenditures represent investments in physical assets such as property, equipment, and infrastructure.
What is Insmed (INSM) free cash flow?: Insmed (INSM) generated −$997.58M in free cash flow for TTM through Q4 2025 (-164.5% of total revenue). Free cash flow is the cash remaining after capital expenditures and represents the company's ability to fund growth, pay dividends, or reduce debt.

Data & methodology

What is a Sankey diagram?: A Sankey diagram shows how money flows through a company from revenue to net profit. The width of each flow represents its proportion.
How is the data calculated?: We use the income statement from company filings. For TTM (Trailing Twelve Months), we use a pre-aggregated twelve-month view aligned with our latest four quarterly periods. Revenue flows to cost of revenue and gross profit, then to operating expenses (R&D, S&M, G&A) and operating profit.
When was this data last updated?: Based on company filings through TTM through Q4 2025.